Skip to content

National Clinical Evidence Taskforce Funding Update

National Clinical Evidence Taskforce logo and partner logos

The National Clinical Evidence Taskforce which ensured Australian have up to date, scientifically sound and trusted updates, is running to the end of its funding on December 31st 2022. It has been exciting be one of the 200+ clinicians providing expert advice. My participation was to contribute the gender equity, women’s health and Culturally and Linguistically Diverse (CALD) lens to the recommendations. It has been a privilege to be a part of of the living guidelines task force and I most will agree that the whole nation has felt better informed because of its effort.

Magdalena Simonis
National Clinical Evidence Taskforce, Women’s Health Expert Advisory Group

15 Dec Notification

Earlier this week the National Clinical Evidence Taskforce was informed that the Commonwealth Department of Health and Aged Care will not be continuing our contract to develop clinical guidelines for COVID-19 beyond December 31, 2022.

As a collaboration of 35 member organisations, we are extremely proud of our shared work over the last 33 months to ensure Australian clinicians have up-to-date, trustworthy, evidence-based guidance to support the best possible care for people with COVID-19.

Our 200+ clinicians and consumers have developed more than 200 recommendations and 22 flowcharts for the management and care of people with COVID-19 covering mild, moderate, severe and critical COVID-19, as well as care for people after COVID-19 and with long COVID. Our guidance covers care in all settings including primary, acute and critical care, and all populations including paediatric and adolescent care; pregnancy and perinatal care; and care of older people and palliative care.

We believe up-to-date guidance to support clinicians caring for people with COVID-19 continues to be vital, especially at a time of rising cases and increasing pressure across the health system.

We thank our funders, partners, members and contributors for their ongoing support and are seeking sources of funding to continue our work in 2023.

National Clinical Evidence Taskforce 


Leave a Reply

Subscribe to our weekly e-Bulletin.

Like to receive AFMW news direct to your email? Please enter your details below to join our list. Please note subscribing to our mailing list does not confer AFMW membership.

* indicates required